USPTO serial 88314341
PAPA & BARKLEY ESSENTIALS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SALES, HEATHER ALISON
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PAPA & BARKLEY ESSENTIALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kamran Fattahi
Kamran Fattahi Law Offices of Kamran Fattahi15303 Ventura Blvd., Suite 900Sherman Oaks, CA 91403United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Essential oils for cosmetic purposes; Essential oils for cosmetic purposes containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Cosmetics; Cosmetics containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Cosmetics, namely, non-medicated body oils; Cosmetics, namely, non-medicated body ointments, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; Cosmetics, namely, non-medicated body oils containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Cosmetics, namely, non-medicated body ointments containing lavender, mint, cardamom, ginger, myrrh, and spearmint, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form; Cosmetics, namely, non-medicated body ointments in drop form and liquid form, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Cosmetics, namely, non-medicated body ointments in drop form and liquid form containing lavender, mint, cardamom, ginger, myrrh, and spearmint, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; Non-medicated body soaks; Non-medicated body soaks containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Electronic cigarette liquid (e-liquid) comprised of essential oils; Electronic cigarette liquid (e-liquid) comprised of essential oils containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint | ACTIVE | — |
| 005 | Mentholated ointment for medical use; Mentholated ointment for medical use containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Medicated skin oils; Medicated skin oils containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Topical analgesics; Topical analgesics containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Analgesic balm; Analgesic balm containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Medicated skin creams and lotions; Medicated skin creams and lotions containing lavender, mint, cardamom, ginger, myrrh, and spearmint; medicated skin care preparations; medicated skin care preparations containing lavender, mint, cardamom, ginger, myrrh, and spearmint; medicated herbal topical creams, gels, skin sprays, balms, liniment and ointments, all for the relief of pain; medicated herbal topical creams, gels, skin sprays, balms, liniment and ointments, all for the relief of pain containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Topical gel for medical and therapeutic treatment of minor aches and pains of muscles and joints; Topical gel for medical and therapeutic treatment of minor aches and pains of muscles and joints containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Nutritional supplements in drop form, capsule form, and liquid form; Nutritional supplements in drop form, capsule form, and liquid form containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Herbal tinctures for medical purposes; Herbal tinctures for medical purposes containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Medicated oral spray for pain; Medicated oral spray for pain containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Nutritional supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in managing and addressing stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement; Nutritional supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in managing and addressing stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Pharmaceutical, medicinal, medicated herbal, medicated botanical, and medicated preparations in the form of salves, concentrates, pastes, extracts, tinctures, and mucous membrane doses, for use in acting upon or caring for pain, muscle tension, muscle spasms, and gastrointestinal illness; Pharmaceutical, medicinal, medicated herbal, medicated botanical, and medicated preparations in the form of salves, concentrates, pastes, extracts, tinctures, and mucous membrane doses, for use in acting upon or caring for pain, muscle tension, muscle spasms, and gastrointestinal illness containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Muscle soaks; Muscle soaks containing lavender, mint, cardamom, ginger, myrrh, and spearmint | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Egg Rock Holdings, LLC
- Other trademarks owned by Egg Rock Holdings, LLC
- Other trademarks owned by MAMMOTH MANAGEMENT, INC.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named PAPA & BARKLEY ESSENTIALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 24, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 24, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 24, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 24, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 24, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 3, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 3, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 13, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 13, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 13, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 13, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 13, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 13, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 29, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 11, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 10, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 10, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 10, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 16, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 14, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 14, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 14, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 30, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 28, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 28, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 28, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 27, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 23, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 23, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 23, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 28, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 3, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 3, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 13, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 26, 2022 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Mar 26, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 28, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 28, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2021 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Apr 30, 2021 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Apr 30, 2021 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Apr 30, 2021 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Dec 15, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 15, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 14, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 14, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 14, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 14, 2020 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Dec 14, 2020 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Dec 14, 2020 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jun 13, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 13, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 13, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 11, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| May 11, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 11, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 4, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 29, 2020 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Apr 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2020 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Oct 29, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2019 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 28, 2019 | NWAP | NEW APPLICATION ENTERED | — |